Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/10/26 16:15 | 7/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Gloria Melanie | NC | O | COO | 3 | S | -860 | 37.62 | 0 | -23 | 242 | D | |||||||||||||||
7/10/26 16:13 | 6/18/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Van Tuyl Christopher | NC | O | GC | 3 | S.d | -824 | 38.03 | 0 | -22 | 181 | D | |||||||||||||||
7/10/26 16:12 | 7/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NC | O | CTO | 3 | S | -1,752 | 37.88 | 0 | -46 | 252 | D | |||||||||||||||
7/6/26 17:01 | 7/2/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 1 | S.d | -119 | 38.48 | 0 | -3 | 254 | D | |||||||||||||||
6/26/26 19:44 | 6/26/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Girao Tiago | NC | O | CFO | 2 | S.d | -1,148 | 32.09 | 0 | -36 | 248 | D | |||||||||||||||
6/26/26 19:43 | 6/26/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NC | D | 3 | S.d | -300 | 33.34 | 0 | -9 | 137 | D | ||||||||||||||||
5/29/26 16:04 | 5/28/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Fromkin Andrew J. | NC | D | 1 | S.d | -7,438 | 33.51 | 0 | -222 | 74 | D | ||||||||||||||||
5/1/26 18:40 | 5/1/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Susman Robert Graham | NC | D | 1 | S | -68 | 27.17 | 0 | -3 | 36 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |